The AstraZeneca Protein and Peptide Science Award - 2023
The Protein and Peptide Science Group are pleased to announce that nominations are open for the 2023 RSC AstraZeneca Protein and Peptide Science Award.
Awarded in recognition of excellence in any area of protein and peptide science.
Self-nominations are permitted and encouraged, and the prize is open to nominees based in the UK or internationally.
Please send the following information to Dr Corinne Kay (Secretary, PPSG) corinne.kay@med-simple.com
- An up to date CV for the nominee (no longer than one A4 side, 11pt text). This should include a summary of their education and career, and a maximum of 5 relevant publications or patents.
- A short citation describing what the nominee should be awarded for. This must be no longer than 250 characters (including spaces) and no longer than one sentence.
- A supporting statement (up to 750 words) addressing the nominee's contributions to protein and peptide science
- A statement (up to 100 words) describing how your nominee has contributed more broadly to the scientific community.
Closing date for nominations 31st March 2023
- The Award winner will be chosen by the RSC Protein and Peptide Science Group committee
- The Award winner will receive £1000, a medal and certificate and will be expected to give a lecture at a meeting organized by the PPSG in the 12 months following the Award
Past Winners
Past winners of the MedImmune Protein and Peptide Science Group Award.
2019 Award Winner - Professor Philip Dawson
The Protein and Peptide Science Group (PPSG) is pleased to announce that the winner of the 2019 Medimmune Protein and Peptide Science Award is Professor Philip Dawson, The Scripps Research Institute.
Phil receives this award for his critical role in the development of native chemical ligation and his ongoing contributions to the development of new resins for the preparation of peptide-thioesters. Phil's examination of unusual peptide backbone chain topologies including protein catenanes, as well as his seminal study of H-bond strengths in beta-sheets rounds out a remarkable series of contributions to peptide and protein science.
2017 Award Winner - Professor Ali Tavassoli
The Protein and Peptide Science Group (PPSG) is pleased to announce that the winner of the 2017 Medimmune Protein and Peptide Science Award is Professor Ali Tavassoli, University of Southampton.
Ali receives this award for his work on genetically-encoded cyclic peptide libraries and their use for identifying inhibitors of a variety of protein-protein interactions. Ali’s work has resulted in several first-in-class protein-protein interaction inhibitors that are currently being developed towards the clinic.
Professor Ali Tavassoli will give the Pleanary Lecture, at the 2018 PPSG Early Stage Researcher Meeting.
2015 Award Winner - Professor David Spring
The Protein and Peptide Science Group (PPSG) is pleased to announce that the winner of the 2015 Medimmune Protein and Peptide Science Award is Prof David Spring, University of Cambridge.
In recent years Prof David Spring has utilised novel strategies in the i, i+7 stapling of α-helical 3.1*8peptide motifs, his two-component approach makes exploration of these factors much simpler than any previous approach.
Prof David Spring received his award and gave the Pleanary Lecture, at the PPSG Early Stage Researcher Meeting in autumn 2015.
2013 Award Winner - Dr Ed Tate
The Protein and Peptide Science Group (PPSG) is pleased to announce that the winner of the 2013 Medimmune Protein and Peptide Science Award is Dr Edward Tate, Imperial College, London.
In recent years Dr Ed Tate has made a significant contribution to chemical approaches for understanding protein post-translational modification, the study of protein-protein interaction inhibitors and the chemical proteomic de novo discovery and validation of drug targets.
Dr Ed Tate will receive his award, and give the Pleanary Lecture, at the PPSG Early Stage Researcher Meeting in autumn 2013.
2011 Award Winner - Professor Derek Woolfson
MedImmune’s Dr Lutz Jermutus, Senior Director, R&D, and Global Head, Technology, based at Cambridge and Fellow of the Royal Society of Chemistry (FRSC), was honoured to be asked to present the 2011 Award at the 2011 PPSG Early Stage Researcher Meeting, organised by Dr Alethea Tabor (UCL) at Burlington House in Central London on 8 November 2011.
The award was made to Professor Derek Woolfson, Professor of Chemistry and Biochemistry at the University of Bristol, UK, in respect of his research group’s outstanding work in understanding the rules that govern peptide and protein folding and self-assembly, and their application in nanotechnology and therapy.
Professor Robin Leatherbarrow of Imperial College London, the Chair of the PPSG, said: “The Committee of the PPSG in making this award were impressed by the work of Professor Woolfson and his research group on a number of counts. Most significantly the Committee members were impressed by the potential applications in bio-nanotechnology, and also by their use in aiding understanding of disease states caused by misfolded proteins.”
Dr Lutz Jermutus, presenting the award on behalf of MedImmune, said: “Professor Woolfson’s research, both within the Bristol Research Group and in collaboration with others, has produced significant discoveries and a number of very high-profile publications in just a few years. Through this award, MedImmune is proud to be the recognising achievement of the very highest level in the field of protein and peptide science.”
Receiving the award, Dr Woolfson, said: “I am delighted to accept this award on behalf of all those involved in our work at the University of Bristol and previously at the University of Sussex. In particular, I am pleased that the Royal Society of Chemistry, with its interdisciplinary approach and a strong focus on the practical applications of molecular science in chemistry, biology, and medicine, has chosen to recognise our work in this way.”